An Unusual Case of Synchronous Metastatic Melanomas With Differing Response to Pembrolizumab.

Doolan, Brent J; McLean, Catriona; Mar, Victoria; Moore, Maggie

Doolan, Brent J; McLean, Catriona; Mar, Victoria; Moore, Maggie.

Affiliation

Doolan BJ; The Alfred Hospital, Melbourne, VIC, Australia.
McLean C; The Alfred Hospital, Melbourne, VIC, Australia.
Mar V; The Alfred Hospital, Melbourne, VIC, Australia.
Moore M; The Alfred Hospital, Melbourne, VIC, Australia.

J Oncol Pract ; 15(3): 159-160, 2019 Mar.

Article in En | MEDLINE | ID: mdl-30861362

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Agents, Immunological/therapeutic use; Melanoma/drug therapy; Melanoma/pathology; Neoplasms, Multiple Primary/drug therapy; Neoplasms, Multiple Primary/pathology; Aged; Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Agents, Immunological/administration & dosage; Antineoplastic Agents, Immunological/adverse effects; Biopsy; Female; Humans; Melanoma/etiology; Neoplasms, Multiple Primary/etiology; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf/genetics; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Antineoplastic Agents, Immunological / Melanoma / Neoplasms, Multiple Primary Type of study: Etiology_studies Limits: Aged / Female / Humans Language: En Journal: J Oncol Pract Year: 2019 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google